Thrombolytic Drug Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Drug Type (Fibrin Specific Drugs, Non- Fibrin Specific); Application (Myocardial Infarction, Pulmonary Embolism, Deep vein thrombosis, Acute ischemic stroke, Others); Distribution Channel (Hospital Pharmacies, Retail pharmacies, Others) and Geography

Report Code: TIPRE00018531 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Thrombolytic drugs are used to dissolve abnormal blood clots. Blood clot is very common and threatening complication in human body. Blood clot can cause blockade of arteries and veins which lead to hemorrhage, stroke and heart attack. Thrombolytic drugs acts by dissolving abnormal blood clots and maintaining normal blood flow. The length of thrombolytic therapy treatment is based upon the degree of complications. Thrombolytic drugs have applications in myocardial infarction, pulmonary embolism, deep vein thrombosis, stroke etc.

MARKET DYNAMICS

The key market drivers for Thrombolytic Drug Market Includes, rising incidences of cardiovascular diseases along with growing ageing population across the globe. Moreover, rising awareness about diagnosis and treatment of thrombosis disorders is also expected to fuel market growth during forecast period. However, stringent regulatory approvals for thrombolytic drugs and high drug pricing are expected to restrain market growth during forecast period.

MARKET SCOPE

The "Thrombolytic Drug Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Thrombolytic Drug market with detailed market segmentation by drug type, application and distribution channel. The Thrombolytic Drug Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Thrombolytic Drug Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Thrombolytic Drug Market is segmented on the basis of drug type, application and distribution channel. On the basis of drug type the market is segmented as, fibrin specific drugs, non-fibrin specific. On the basis of application the market is segmented as, myocardial infarction, pulmonary embolism, deep vein thrombosis. And on the basis of distribution channel the market is segmented as, hospital pharmacies, retail pharmacies and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Thrombolytic Drug Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Thrombolytic Drug Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Thrombolytic Drug Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Thrombolytic Drug Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Thrombolytic Drug Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Thrombolytic Drug Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Thrombolytic Drug market in the global market. Below mentioned is the list of few companies engaged in the Thrombolytic Drug Market.

The report also includes the profiles of key players in Thrombolytic Drug Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Bristol-Myers Squibb Company
  •   AstraZeneca plc.
  •   Eli Lilly and Company
  •   C.H Boehringer Sohn AG & ko. KG
  •   Aspen Holdings
  •   Eumedica
  •   Genentech
  •   Microbix
  •   Taj Pharmaceuticals Ltd.
  •   Syner-Medica

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Thrombolytic Drug Market - By Drug Type
1.3.2 Thrombolytic Drug Market - By Application
1.3.3 Thrombolytic Drug Market - By Distribution Channel
1.3.4 Thrombolytic Drug Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. THROMBOLYTIC DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. THROMBOLYTIC DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. THROMBOLYTIC DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. THROMBOLYTIC DRUG - GLOBAL MARKET OVERVIEW
6.2. THROMBOLYTIC DRUG - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. THROMBOLYTIC DRUG MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. FIBRIN SPECIFIC DRUGS
7.3.1. Overview
7.3.2. Fibrin Specific Drugs Market Forecast and Analysis
7.3.3. Tissue plasminogen activator Market
7.3.3.1. Overview
7.3.3.2. Tissue plasminogen activator Market Forecast and Analysis
7.3.4. Reteplase Market
7.3.4.1. Overview
7.3.4.2. Reteplase Market Forecast and Analysis
7.3.5. Tenecteplase Market
7.3.5.1. Overview
7.3.5.2. Tenecteplase Market Forecast and Analysis
7.3.6. Others Market
7.3.6.1. Overview
7.3.6.2. Others Market Forecast and Analysis
7.4. NON- FIBRIN SPECIFIC
7.4.1. Overview
7.4.2. Non- Fibrin Specific Market Forecast and Analysis
7.4.3. Urokinase Market
7.4.3.1. Overview
7.4.3.2. Urokinase Market Forecast and Analysis
7.4.4. Streptokinase Market
7.4.4.1. Overview
7.4.4.2. Streptokinase Market Forecast and Analysis
7.4.5. Plasminogen-activating complex Market
7.4.5.1. Overview
7.4.5.2. Plasminogen-activating complex Market Forecast and Analysis
8. THROMBOLYTIC DRUG MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. MYOCARDIAL INFARCTION
8.3.1. Overview
8.3.2. Myocardial Infarction Market Forecast and Analysis
8.4. PULMONARY EMBOLISM
8.4.1. Overview
8.4.2. Pulmonary Embolism Market Forecast and Analysis
8.5. DEEP VEIN THROMBOSIS
8.5.1. Overview
8.5.2. Deep vein thrombosis Market Forecast and Analysis
8.6. ACUTE ISCHEMIC STROKE
8.6.1. Overview
8.6.2. Acute ischemic stroke Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. THROMBOLYTIC DRUG MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail pharmacies Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis

10. THROMBOLYTIC DRUG MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Thrombolytic Drug Market Overview
10.1.2 North America Thrombolytic Drug Market Forecasts and Analysis
10.1.3 North America Thrombolytic Drug Market Forecasts and Analysis - By Drug Type
10.1.4 North America Thrombolytic Drug Market Forecasts and Analysis - By Application
10.1.5 North America Thrombolytic Drug Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Thrombolytic Drug Market Forecasts and Analysis - By Countries
10.1.6.1 United States Thrombolytic Drug Market
10.1.6.1.1 United States Thrombolytic Drug Market by Drug Type
10.1.6.1.2 United States Thrombolytic Drug Market by Application
10.1.6.1.3 United States Thrombolytic Drug Market by Distribution Channel
10.1.6.2 Canada Thrombolytic Drug Market
10.1.6.2.1 Canada Thrombolytic Drug Market by Drug Type
10.1.6.2.2 Canada Thrombolytic Drug Market by Application
10.1.6.2.3 Canada Thrombolytic Drug Market by Distribution Channel
10.1.6.3 Mexico Thrombolytic Drug Market
10.1.6.3.1 Mexico Thrombolytic Drug Market by Drug Type
10.1.6.3.2 Mexico Thrombolytic Drug Market by Application
10.1.6.3.3 Mexico Thrombolytic Drug Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Thrombolytic Drug Market Overview
10.2.2 Europe Thrombolytic Drug Market Forecasts and Analysis
10.2.3 Europe Thrombolytic Drug Market Forecasts and Analysis - By Drug Type
10.2.4 Europe Thrombolytic Drug Market Forecasts and Analysis - By Application
10.2.5 Europe Thrombolytic Drug Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Thrombolytic Drug Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Thrombolytic Drug Market
10.2.6.1.1 Germany Thrombolytic Drug Market by Drug Type
10.2.6.1.2 Germany Thrombolytic Drug Market by Application
10.2.6.1.3 Germany Thrombolytic Drug Market by Distribution Channel
10.2.6.2 France Thrombolytic Drug Market
10.2.6.2.1 France Thrombolytic Drug Market by Drug Type
10.2.6.2.2 France Thrombolytic Drug Market by Application
10.2.6.2.3 France Thrombolytic Drug Market by Distribution Channel
10.2.6.3 Italy Thrombolytic Drug Market
10.2.6.3.1 Italy Thrombolytic Drug Market by Drug Type
10.2.6.3.2 Italy Thrombolytic Drug Market by Application
10.2.6.3.3 Italy Thrombolytic Drug Market by Distribution Channel
10.2.6.4 Spain Thrombolytic Drug Market
10.2.6.4.1 Spain Thrombolytic Drug Market by Drug Type
10.2.6.4.2 Spain Thrombolytic Drug Market by Application
10.2.6.4.3 Spain Thrombolytic Drug Market by Distribution Channel
10.2.6.5 United Kingdom Thrombolytic Drug Market
10.2.6.5.1 United Kingdom Thrombolytic Drug Market by Drug Type
10.2.6.5.2 United Kingdom Thrombolytic Drug Market by Application
10.2.6.5.3 United Kingdom Thrombolytic Drug Market by Distribution Channel
10.2.6.6 Rest of Europe Thrombolytic Drug Market
10.2.6.6.1 Rest of Europe Thrombolytic Drug Market by Drug Type
10.2.6.6.2 Rest of Europe Thrombolytic Drug Market by Application
10.2.6.6.3 Rest of Europe Thrombolytic Drug Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Thrombolytic Drug Market Overview
10.3.2 Asia-Pacific Thrombolytic Drug Market Forecasts and Analysis
10.3.3 Asia-Pacific Thrombolytic Drug Market Forecasts and Analysis - By Drug Type
10.3.4 Asia-Pacific Thrombolytic Drug Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Thrombolytic Drug Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Thrombolytic Drug Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Thrombolytic Drug Market
10.3.6.1.1 Australia Thrombolytic Drug Market by Drug Type
10.3.6.1.2 Australia Thrombolytic Drug Market by Application
10.3.6.1.3 Australia Thrombolytic Drug Market by Distribution Channel
10.3.6.2 China Thrombolytic Drug Market
10.3.6.2.1 China Thrombolytic Drug Market by Drug Type
10.3.6.2.2 China Thrombolytic Drug Market by Application
10.3.6.2.3 China Thrombolytic Drug Market by Distribution Channel
10.3.6.3 India Thrombolytic Drug Market
10.3.6.3.1 India Thrombolytic Drug Market by Drug Type
10.3.6.3.2 India Thrombolytic Drug Market by Application
10.3.6.3.3 India Thrombolytic Drug Market by Distribution Channel
10.3.6.4 Japan Thrombolytic Drug Market
10.3.6.4.1 Japan Thrombolytic Drug Market by Drug Type
10.3.6.4.2 Japan Thrombolytic Drug Market by Application
10.3.6.4.3 Japan Thrombolytic Drug Market by Distribution Channel
10.3.6.5 South Korea Thrombolytic Drug Market
10.3.6.5.1 South Korea Thrombolytic Drug Market by Drug Type
10.3.6.5.2 South Korea Thrombolytic Drug Market by Application
10.3.6.5.3 South Korea Thrombolytic Drug Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Thrombolytic Drug Market
10.3.6.6.1 Rest of Asia-Pacific Thrombolytic Drug Market by Drug Type
10.3.6.6.2 Rest of Asia-Pacific Thrombolytic Drug Market by Application
10.3.6.6.3 Rest of Asia-Pacific Thrombolytic Drug Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Thrombolytic Drug Market Overview
10.4.2 Middle East and Africa Thrombolytic Drug Market Forecasts and Analysis
10.4.3 Middle East and Africa Thrombolytic Drug Market Forecasts and Analysis - By Drug Type
10.4.4 Middle East and Africa Thrombolytic Drug Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Thrombolytic Drug Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Thrombolytic Drug Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Thrombolytic Drug Market
10.4.6.1.1 South Africa Thrombolytic Drug Market by Drug Type
10.4.6.1.2 South Africa Thrombolytic Drug Market by Application
10.4.6.1.3 South Africa Thrombolytic Drug Market by Distribution Channel
10.4.6.2 Saudi Arabia Thrombolytic Drug Market
10.4.6.2.1 Saudi Arabia Thrombolytic Drug Market by Drug Type
10.4.6.2.2 Saudi Arabia Thrombolytic Drug Market by Application
10.4.6.2.3 Saudi Arabia Thrombolytic Drug Market by Distribution Channel
10.4.6.3 U.A.E Thrombolytic Drug Market
10.4.6.3.1 U.A.E Thrombolytic Drug Market by Drug Type
10.4.6.3.2 U.A.E Thrombolytic Drug Market by Application
10.4.6.3.3 U.A.E Thrombolytic Drug Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Thrombolytic Drug Market
10.4.6.4.1 Rest of Middle East and Africa Thrombolytic Drug Market by Drug Type
10.4.6.4.2 Rest of Middle East and Africa Thrombolytic Drug Market by Application
10.4.6.4.3 Rest of Middle East and Africa Thrombolytic Drug Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Thrombolytic Drug Market Overview
10.5.2 South and Central America Thrombolytic Drug Market Forecasts and Analysis
10.5.3 South and Central America Thrombolytic Drug Market Forecasts and Analysis - By Drug Type
10.5.4 South and Central America Thrombolytic Drug Market Forecasts and Analysis - By Application
10.5.5 South and Central America Thrombolytic Drug Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Thrombolytic Drug Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Thrombolytic Drug Market
10.5.6.1.1 Brazil Thrombolytic Drug Market by Drug Type
10.5.6.1.2 Brazil Thrombolytic Drug Market by Application
10.5.6.1.3 Brazil Thrombolytic Drug Market by Distribution Channel
10.5.6.2 Argentina Thrombolytic Drug Market
10.5.6.2.1 Argentina Thrombolytic Drug Market by Drug Type
10.5.6.2.2 Argentina Thrombolytic Drug Market by Application
10.5.6.2.3 Argentina Thrombolytic Drug Market by Distribution Channel
10.5.6.3 Rest of South and Central America Thrombolytic Drug Market
10.5.6.3.1 Rest of South and Central America Thrombolytic Drug Market by Drug Type
10.5.6.3.2 Rest of South and Central America Thrombolytic Drug Market by Application
10.5.6.3.3 Rest of South and Central America Thrombolytic Drug Market by Distribution Channel

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. THROMBOLYTIC DRUG MARKET, KEY COMPANY PROFILES
12.1. BRISTOL-MYERS SQUIBB COMPANY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ASTRAZENECA PLC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ELI LILLY AND COMPANY
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. C.H. BOEHRINGER SOHN AG & KO. KG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ASPEN HOLDINGS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. EUMEDICA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GENENTECH
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MICROBIX
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TAJ PHARMACEUTICALS LTD
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SYNER-MEDICA
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Bristol-Myers Squibb Company
2. AstraZeneca plc
3. Eli Lilly and Company
4. C.H. Boehringer Sohn AG & Ko. KG
5. Aspen Holdings
6. Eumedica
7. Genentech
8. Microbix
9. Taj Pharmaceuticals Ltd
10. Syner-Medica
TIPRE00018531
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking